# A Randomized Trial of Angiotensin Receptor bLocker,Fimasartan, in Aortic Stenosis (ALFA Trial)

> **NCT01589380** · PHASE4 · UNKNOWN · sponsor: **Seoul National University Hospital** · enrollment: 100 (estimated)

## Conditions studied

- Critical Stenosis of Aortic Valve

## Interventions

- **DRUG:** Fimasartan
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01589380
- **Lead sponsor:** Seoul National University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2012-04
- **Primary completion:** 2013-05
- **Final completion:** 2014-12
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2012-05-02

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01589380

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01589380, "A Randomized Trial of Angiotensin Receptor bLocker,Fimasartan, in Aortic Stenosis (ALFA Trial)". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT01589380. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*